which companies make glp-1 drugs 2.0: Where the Next Wave of Value Will Be Created GLP-1 Medications for Weight Loss:

Baynest HW

These include modulation of orexin signaling and the HPA axis in opioid models, engagement of lateral septal and habenular circuits in psychostimulant models, and dopamine catabolism and hippocampal effects in alcohol paradigms

Published 2024 May 17

Orforglipron significantly improved those parameters compared with controls

GLP-1 RAs offer a dual central and peripheral mechanism against SLD progression

One study explained that while the patient followed current guidelines, shortly prior to extubation, the patient developed large-volume emesis with contents consistent with food the patient reported eating several days prior (Beam and Hunter Guevara 2023)